General MedicationsORALGeneric

KYTRIL

GRANISETRON HYDROCHLORIDE

Standard Dose

EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview KYTRIL is listed in Drugs@FDA under application 020305 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient GRANISETRON HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** Sponsor ROCHE Submission history Latest submission status date: 2009-10-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview KYTRIL is listed in Drugs@FDA under application 020305 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GRANISETRON HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** Sponsor ROCHE Submission history Latest submission status date: 2009-10-07 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.